Tuesday, Jun 25, 2024 · SEC filings
What the smart money revealed on Jun 25
417 insider filings came in. We hid 45 planned (10b5-1) sellers and 277 people whose filings were routine, like grants and tax withholding.
Liberty Latin America (LILA) Director Brendan Paddick bought $3.58M
400,000 shares on the open market. Not a grant or an option exercise. Their past buys: 0 of 3 checked quarters beat the typical stock 6 months later.
Nuvation Bio (NUVB) Director Xiangmin Cui bought $1.49M
500,000 shares on the open market. Not a grant or an option exercise.
Nexpoint Diversified Real Estate Trust (NXDT) Officer James Dondero bought $198K
40,471 shares on the open market. Not a grant or an option exercise. Their past buys: 1 of 4 checked quarters beat the typical stock 6 months later.
Athira Pharma (LONA) Director Kelly Romano bought $100K
42,400 shares on the open market. Not a grant or an option exercise.
Elastic N.V. (ESTC) CTO Shay Banon sold $32.5M
Not marked as a planned 10b5-1 sale. Sold 10% of the shares they held directly. Still holds 2.75M shares.
nCino (NCNO) Director Jeff Horing sold $24.6M
Not marked as a planned 10b5-1 sale. Sold 3% of the shares they held directly. Still holds 25.66M shares.
Ingles Markets (IMKTA) Director Sharp Ingle sold $338K
Not marked as a planned 10b5-1 sale. Sold 45% of the shares they held directly. Still holds 5,901 shares.
Show 11 more real buys
Show 50 more real sales
13F season
Holdings as of Mar 31, 2024 were due May 15
50 funds have filed. 49 filed for the quarter before.
Biggest real insider buys, Jun 19–25
Open-market buys by officers and directors, filed in the 7 days up to Jun 25.
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.